287 related articles for article (PubMed ID: 29223097)
21. Peloruside A, a novel antimitotic agent with paclitaxel-like microtubule- stabilizing activity.
Hood KA; West LM; Rouwé B; Northcote PT; Berridge MV; Wakefield SJ; Miller JH
Cancer Res; 2002 Jun; 62(12):3356-60. PubMed ID: 12067973
[TBL] [Abstract][Full Text] [Related]
22. Anticancer drugs from nature--natural products as a unique source of new microtubule-stabilizing agents.
Altmann KH; Gertsch J
Nat Prod Rep; 2007 Apr; 24(2):327-57. PubMed ID: 17390000
[TBL] [Abstract][Full Text] [Related]
23. Taccalonolide binding to tubulin imparts microtubule stability and potent in vivo activity.
Risinger AL; Li J; Bennett MJ; Rohena CC; Peng J; Schriemer DC; Mooberry SL
Cancer Res; 2013 Nov; 73(22):6780-92. PubMed ID: 24048820
[TBL] [Abstract][Full Text] [Related]
24. The coral-derived natural products eleutherobin and sarcodictyins A and B: effects on the assembly of purified tubulin with and without microtubule-associated proteins and binding at the polymer taxoid site.
Hamel E; Sackett DL; Vourloumis D; Nicolaou KC
Biochemistry; 1999 Apr; 38(17):5490-8. PubMed ID: 10220336
[TBL] [Abstract][Full Text] [Related]
25. Taccalonolide Microtubule Stabilizers.
Yee SS; Du L; Risinger AL
Prog Chem Org Nat Prod; 2020; 112():183-206. PubMed ID: 33306174
[TBL] [Abstract][Full Text] [Related]
26. Similarity-based virtual screening for microtubule stabilizers reveals novel antimitotic scaffold.
Ayoub AT; Klobukowski M; Tuszynski J
J Mol Graph Model; 2013 Jul; 44():188-96. PubMed ID: 23871820
[TBL] [Abstract][Full Text] [Related]
27. Microtubule-stabilizing natural products as promising cancer therapeutics.
Gallagher BM
Curr Med Chem; 2007; 14(28):2959-67. PubMed ID: 18220732
[TBL] [Abstract][Full Text] [Related]
28. Physiochemical aspects of tubulin-interacting antimitotic drugs.
Correia JJ; Lobert S
Curr Pharm Des; 2001 Sep; 7(13):1213-28. PubMed ID: 11472263
[TBL] [Abstract][Full Text] [Related]
29. Epothilone analogues with benzimidazole and quinoline side chains: chemical synthesis, antiproliferative activity, and interactions with tubulin.
Dietrich SA; Lindauer R; Stierlin C; Gertsch J; Matesanz R; Notararigo S; Díaz JF; Altmann KH
Chemistry; 2009 Oct; 15(39):10144-57. PubMed ID: 19697384
[TBL] [Abstract][Full Text] [Related]
30. Taccalonolide microtubule stabilizers.
Li J; Risinger AL; Mooberry SL
Bioorg Med Chem; 2014 Sep; 22(18):5091-6. PubMed ID: 24491636
[TBL] [Abstract][Full Text] [Related]
31. Microtubule stabilizing agents: their molecular signaling consequences and the potential for enhancement by drug combination.
Bergstralh DT; Ting JP
Cancer Treat Rev; 2006 May; 32(3):166-79. PubMed ID: 16527420
[TBL] [Abstract][Full Text] [Related]
32. Insights into the Distinct Mechanisms of Action of Taxane and Non-Taxane Microtubule Stabilizers from Cryo-EM Structures.
Kellogg EH; Hejab NMA; Howes S; Northcote P; Miller JH; Díaz JF; Downing KH; Nogales E
J Mol Biol; 2017 Mar; 429(5):633-646. PubMed ID: 28104363
[TBL] [Abstract][Full Text] [Related]
33. Synergistic interactions between peloruside A and other microtubule-stabilizing and destabilizing agents in cultured human ovarian carcinoma cells and murine T cells.
Wilmes A; O'Sullivan D; Chan A; Chandrahasen C; Paterson I; Northcote PT; La Flamme AC; Miller JH
Cancer Chemother Pharmacol; 2011 Jul; 68(1):117-26. PubMed ID: 20848285
[TBL] [Abstract][Full Text] [Related]
34. 3D QSAR models of interactions between beta-tubulin and microtubule stabilizing antimitotic agents (MSAA): a survey on taxanes and epothilones.
Manetti F; Maccari L; Corelli F; Botta M
Curr Top Med Chem; 2004; 4(2):203-17. PubMed ID: 14754454
[TBL] [Abstract][Full Text] [Related]
35. Potent taccalonolides, AF and AJ, inform significant structure-activity relationships and tubulin as the binding site of these microtubule stabilizers.
Li J; Risinger AL; Peng J; Chen Z; Hu L; Mooberry SL
J Am Chem Soc; 2011 Nov; 133(47):19064-7. PubMed ID: 22040100
[TBL] [Abstract][Full Text] [Related]
36. Synergistic effects of peloruside A and laulimalide with taxoid site drugs, but not with each other, on tubulin assembly.
Hamel E; Day BW; Miller JH; Jung MK; Northcote PT; Ghosh AK; Curran DP; Cushman M; Nicolaou KC; Paterson I; Sorensen EJ
Mol Pharmacol; 2006 Nov; 70(5):1555-64. PubMed ID: 16887932
[TBL] [Abstract][Full Text] [Related]
37. Hallmarks of molecular action of microtubule stabilizing agents: effects of epothilone B, ixabepilone, peloruside A, and laulimalide on microtubule conformation.
Khrapunovich-Baine M; Menon V; Yang CP; Northcote PT; Miller JH; Angeletti RH; Fiser A; Horwitz SB; Xiao H
J Biol Chem; 2011 Apr; 286(13):11765-78. PubMed ID: 21245138
[TBL] [Abstract][Full Text] [Related]
38. The taccalonolides and paclitaxel cause distinct effects on microtubule dynamics and aster formation.
Risinger AL; Riffle SM; Lopus M; Jordan MA; Wilson L; Mooberry SL
Mol Cancer; 2014 Feb; 13():41. PubMed ID: 24576146
[TBL] [Abstract][Full Text] [Related]
39. Anti-tubulin agents of natural origin: Targeting taxol, vinca, and colchicine binding domains.
Naaz F; Haider MR; Shafi S; Yar MS
Eur J Med Chem; 2019 Jun; 171():310-331. PubMed ID: 30953881
[TBL] [Abstract][Full Text] [Related]
40. Cyclostreptin (FR182877), an antitumor tubulin-polymerizing agent deficient in enhancing tubulin assembly despite its high affinity for the taxoid site.
Edler MC; Buey RM; Gussio R; Marcus AI; Vanderwal CD; Sorensen EJ; Díaz JF; Giannakakou P; Hamel E
Biochemistry; 2005 Aug; 44(34):11525-38. PubMed ID: 16114889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
